Mesalamine
- Product NDC
- 50268-577
- 11-digit product format
- 502680577
- Labeler code
- 50268
- Product ID
- 50268-577_2b4a9376-8515-3d10-e063-6394a90a0aad
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Mesalamine
- Dosage form
- CAPSULE, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- AvPAK
- Application
- ANDA214242
- Marketing category
- ANDA
- Marketing start
- 2023-01-16
- Substance
- MESALAMINE
- Active strength
- .375 g/1
- Pharmacologic classes
- Aminosalicylate [EPC], Aminosalicylic Acids [CS]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Mesalamine
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| MESALAMINE | .375 g/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 4Q81I59GXC |
| Rxcui | 825130 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 50268-577-11 | Mesalamine | 1 in 1 BLISTER PACK | CAPSULE, EXTENDED RELEASE | 1 | | 2 |
| 50268-577-15 | Mesalamine | 50 in 1 BOX | CAPSULE, EXTENDED RELEASE | 50 | | 2 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 50268-577 | MESALAMINE CAPSULE, EXTENDED RELEASE [AVPAK] | 2 | Current NDC, 2 package rows | 20250112_f2657911-6f06-71fb-e053-2a95a90ae6f7.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 50268-577-11 | 50268057711 | 1 in 1 BLISTER PACK | | | | | Historical |
| 50268-577-15 | 50268057715 | 50 BLISTER PACK in 1 BOX (50268-577-15) / 1 CAPSULE, EXTENDED RELEASE in 1 BLISTER PACK (50268-577-11) | 50 blister pack | 2023-01-16 | No | No | Historical |